Neurocognitive challenges in brain tumor survivors: is there anything we can do?
- PMID: 25897161
- PMCID: PMC4812563
- DOI: 10.1200/JCO.2014.60.2805
Neurocognitive challenges in brain tumor survivors: is there anything we can do?
Conflict of interest statement
Disclosures provided by the authors are available with this article at
Neurocognitive Challenges in Brain Tumor Survivors: Is There Anything We Can Do?
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO’s conflict of interest policy, please refer to
No relationship to disclose
Comment on
-
Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial.J Clin Oncol. 2015 May 20;33(15):1653-9. doi: 10.1200/JCO.2014.58.4508. Epub 2015 Apr 20. J Clin Oncol. 2015. PMID: 25897156 Free PMC article. Clinical Trial.
References
-
- Shaw EG, Rosdhal R, D’Agostino RB, Jr, et al. Phase II study of donepezil in irradiated brain tumor patients: Effect on cognitive function, mood, and quality of life. J Clin Oncol. 2006;24:1415–1420. - PubMed
-
- Duffau H, Mandonnet E. The “onco-functional balance” in surgery for diffuse low-grade glioma: Integrating the extent of resection with quality of life. Acta Neurochir (Wien) 2013;155:951–957. - PubMed
-
- DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology. 1989;39:789–796. - PubMed
-
- Klein M, Heimans JJ, Aaronson NK, et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: A comparative study. Lancet. 2002;360:1361–1368. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
